Viatris Inc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.3 | $14.7 | $15.4 | $16.2 | $17.8 |
| Operating income | -$2.7 | $<0.1 | $0.8 | $1.6 | -$<0.1 |
| Net income | -$3.5 | -$0.6 | $0.1 | $2.1 | -$1.3 |
| Balance Sheet | |||||
| Total debt | $14.0 | $13.6 | $17.6 | $18.7 | $20.9 |
| Cash Flow Statement | |||||
| Free cash flow | $1.9 | $2.0 | $2.5 | $2.6 | $2.6 |
| Share repurchases | $0.5 | $0.2 | $0.2 | $0.0 | $0.0 |
Shares outstanding 1.1B · Free float 99.6%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.
Earnings
Other Coverage
October 10, 2026
Weekly Deals
Schneider Electric signs $22.6 billion cash deal for PTC
October 8, 2026
Deals
Viatris to Buy Pacira BioSciences in $1.65 Billion Cash Deal
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back